Company: STAA
Filing Date: 2025-09-16
Form Type: DEFM14A
Source: 0001193125-25-204396
Chunk: 7

Company: STAAR SURGICAL CO
Filing Date: 2025-09-16
Form: DEFM14A
Chunk 7
---
 but not otherwise defined herein has the meaning assigned to such term in the Merger Agreement.

Parties Involved in the Merger

STAAR Surgical Company

STAAR
Surgical Company (NASDAQ: STAA) is a global leader in implantable phakic intraocular lenses, a vision correction solution that reduces or eliminates the need for glasses or contact lenses. Since 1982, STAAR has been dedicated solely to ophthalmic
surgery, and for 30 years, STAAR has been designing, developing, manufacturing, and marketing advanced Implantable Collamer Lenses (“ICLs”), using its proprietary
biocompatible Collamer material. STAAR ICL’s are clinically-proven to deliver safe long-term vision correction without removing corneal tissue or the eye’s natural crystalline lens. Its EVO ICL product line provides visual freedom through a quick, minimally invasive procedure. STAAR has sold more than 3 million ICLs in over 75 countries. Headquartered in Lake Forest,
California, STAAR operates research, development, manufacturing, and packaging facilities in California and Switzerland. For more information about ICL, visit www.EVOICL.com. To learn more about STAAR, visit www.staar.com.

STAAR’s principal executive offices are located at 25510 Commercentre Drive, Lake Forest, California 92630, and its telephone number is
(626) 303-7902. STAAR common stock is listed on NASDAQ under the symbol “STAA.”

Alcon Research, LLC

Alcon is a Delaware limited liability company. Its principal executive offices are located at 6201 South Freeway, Fort Worth,
Texas 76134, and its telephone number is (817) 293-0450. Alcon is an indirect wholly owned subsidiary of Alcon Inc. Alcon Inc.’s ordinary shares are listed on the New York Stock Exchange and SIX Swiss
Exchange under the symbol “ALC.”

-1-

Alcon Inc. helps people see brilliantly. As a global leader in eye care with a heritage
spanning more than 75 years, Alcon Inc. offers the broadest portfolio of products to enhance sight and improve people’s lives. Alcon Inc.’s surgical and vision care products touch the lives of more than 260 million people in over
140 countries each year living with conditions like cataracts, glaucoma, retinal diseases, and refractive errors.

Rascasse Merger Sub, Inc.

Mer